| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |